Ken Sonnenfeld, PhD
Panelist, Roundtable Discussion: Is Open Source a Feasible Model for Biotech?
Partner, King & Spalding LLC
Dr. Sonnenfeld is a partner in the Intellectual Property group in the New York office. He has been practicing biotechnology and pharmaceutical patent law for almost twenty years. His practice includes representing clients in managing and strategizing complex patent prosecution, including interferences, reissues and reexaminations, patent infringement litigation, due diligence, licensing and counseling. Dr. Sonnenfeld's clients include both large multinational corporations, start up companies and non-profit foundations. Dr. Sonnenfeld received his M.A., M.Phil and Ph.D. in pharmacology from Columbia University and his J.D. from Fordham University Law School.
